Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Other Non Operating Income: 2023-2024

Historic Other Non Operating Income for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $3,000.

  • CG Oncology's Other Non Operating Income fell 4900.00% to -$100,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$93,000, marking a year-over-year decrease of 1228.57%. This contributed to the annual value of $3,000 for FY2024, which is 104.84% up from last year.
  • Latest data reveals that CG Oncology reported Other Non Operating Income of $3,000 as of FY2024, which was up 104.84% from -$62,000 recorded in FY2023.
  • In the past 5 years, CG Oncology's Other Non Operating Income registered a high of $3,000 during FY2024, and its lowest value of -$62,000 during FY2023.
  • Its 2-year average for Other Non Operating Income is -$29,500, with a median of -$29,500 in 2023.
  • Data for CG Oncology's Other Non Operating Income shows a peak YoY surged of 104.84% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows CG Oncology's Other Non Operating Income stood at -$62,000 in 2023, then skyrocketed by 104.84% to $3,000 in 2024.